What are the barriers to physical activity in patients with chronic plaque psoriasis?
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
accepted:
23
02
2020
pubmed:
29
2
2020
medline:
15
5
2021
entrez:
29
2
2020
Statut:
ppublish
Résumé
Psoriasis is associated with an increased risk of cardiovascular disease. Despite recommendation that exercise is important for cardiorespiratory fitness, patients with psoriasis avoid participation in physical activities for reasons that are, as yet, unclear. This study investigated the relationship between psoriasis-specific experiences and self-reported patterns of exercise, hypothesizing that individuals with psoriasis are less likely to engage in physical activity for reasons that are related to their psoriasis. In total 404 patients with chronic plaque psoriasis were recruited. History, examination and physical activity were assessed for each participant. Overall, 52·8% (n = 188) of patients with psoriasis aged 18-65 years and 66% (n = 37) of those aged > 65 years engaged in less than the recommended amount of physical activity for cardiorespiratory fitness. As the severity and psychosocial impact of psoriasis increased, the participation in exercise (of all intensities) decreased. There was a significant negative correlation between Psoriasis Area and Severity Index and total activity in women aged 18-65 years (r = -0·19, 95% confidence interval -0·36 to 0; P = 0·04) and a significant negative correlation between physical activity and Dermatology Life Quality Index (DLQI) in all participants (r = -0·11, 95% confidence interval -0·21 to 0; P = 0·04). Individual components of the DLQI identified barriers to physical activity including skin sensitivity and reluctance to participate in leisure activities. Psoriasis-specific factors - severity, skin sensitivity, clothing choice, participation in social/leisure activities, and treatments - contribute to exercise avoidance and may augment the increased risk of cardiovascular disease in patients with psoriasis.
Sections du résumé
BACKGROUND
Psoriasis is associated with an increased risk of cardiovascular disease. Despite recommendation that exercise is important for cardiorespiratory fitness, patients with psoriasis avoid participation in physical activities for reasons that are, as yet, unclear.
OBJECTIVES
This study investigated the relationship between psoriasis-specific experiences and self-reported patterns of exercise, hypothesizing that individuals with psoriasis are less likely to engage in physical activity for reasons that are related to their psoriasis.
METHODS
In total 404 patients with chronic plaque psoriasis were recruited. History, examination and physical activity were assessed for each participant.
RESULTS
Overall, 52·8% (n = 188) of patients with psoriasis aged 18-65 years and 66% (n = 37) of those aged > 65 years engaged in less than the recommended amount of physical activity for cardiorespiratory fitness. As the severity and psychosocial impact of psoriasis increased, the participation in exercise (of all intensities) decreased. There was a significant negative correlation between Psoriasis Area and Severity Index and total activity in women aged 18-65 years (r = -0·19, 95% confidence interval -0·36 to 0; P = 0·04) and a significant negative correlation between physical activity and Dermatology Life Quality Index (DLQI) in all participants (r = -0·11, 95% confidence interval -0·21 to 0; P = 0·04). Individual components of the DLQI identified barriers to physical activity including skin sensitivity and reluctance to participate in leisure activities.
CONCLUSIONS
Psoriasis-specific factors - severity, skin sensitivity, clothing choice, participation in social/leisure activities, and treatments - contribute to exercise avoidance and may augment the increased risk of cardiovascular disease in patients with psoriasis.
Identifiants
pubmed: 32107775
doi: 10.1111/bjd.18979
pmc: PMC7754450
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1094-1102Subventions
Organisme : Psoriasis Association
ID : R115290
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Références
J Invest Dermatol. 2005 Jul;125(1):61-7
pubmed: 15982303
Br J Dermatol. 2011 May;164 Suppl 1:1-14
pubmed: 21477010
Int J Dermatol. 2013 Sep;52(9):1129-34
pubmed: 23879519
Br J Dermatol. 2014 Mar;170(3):634-42
pubmed: 24641585
J Eur Acad Dermatol Venereol. 2012 Nov;26(11):1345-53
pubmed: 22385402
Int J Dermatol. 2006 Apr;45(4):418-24
pubmed: 16650169
Circulation. 2003 Jan 7;107(1):e2-5
pubmed: 12515760
J Psychosom Res. 1997 May;42(5):467-75
pubmed: 9194019
Int J Public Health. 2007;52(1):8-15
pubmed: 17966815
Am J Clin Dermatol. 2014 Apr;15(2):129-35
pubmed: 24464933
Br J Dermatol. 2006 Feb;154(2):325-31
pubmed: 16433804
J Am Acad Dermatol. 2006 Apr;54(4):614-21
pubmed: 16546581
Arch Dermatol. 2009 Apr;145(4):379-82
pubmed: 19380659
Am J Med. 2009 Dec;122(12):1150.e1-9
pubmed: 19958894
Br J Dermatol. 1988 Feb;118(2):195-201
pubmed: 3348965
J Eur Acad Dermatol Venereol. 2000 Jul;14(4):267-71
pubmed: 11204514
Med Sci Sports Exerc. 2008 Jan;40(1):181-8
pubmed: 18091006
Br J Dermatol. 2017 Dec;177(6):1463-1465
pubmed: 29313938
Int J Dermatol. 1995 Oct;34(10):700-3
pubmed: 8537157
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
J Invest Dermatol. 2013 Feb;133(2):377-85
pubmed: 23014338
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
pubmed: 21694556
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Med Sci Sports Exerc. 2014 Jan;46(1):99-106
pubmed: 23793232
J Eur Acad Dermatol Venereol. 2015 Mar;29(3):515-20
pubmed: 25132013
J Nutr. 2010 Mar;140(3):648-52
pubmed: 20107145
J Behav Med. 2003 Jun;26(3):211-24
pubmed: 12845935
J Eur Acad Dermatol Venereol. 2010 Sep;24(9):989-1004
pubmed: 20477920
Circulation. 2007 Aug 28;116(9):1094-105
pubmed: 17671236
J Invest Dermatol. 2013 Aug;133(8):1956-62
pubmed: 23807685
Br J Dermatol. 2008 Nov;159(5):997-1035
pubmed: 18795920
Br J Dermatol. 2005 May;152(5):861-7
pubmed: 15888138
Actas Dermosifiliogr. 2009 Dec;100 Suppl 2:14-21
pubmed: 20096157
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
J Invest Dermatol. 2013 Oct;133(10):2340-2346
pubmed: 23528816
J Dermatolog Treat. 2014 Feb;25(1):2-7
pubmed: 23062034
Circulation. 2007 Aug 28;116(9):1081-93
pubmed: 17671237
Women Health. 1992;19(4):15-29
pubmed: 1295266
Br J Dermatol. 2014 Nov;171(5):1116-22
pubmed: 24981809
Control Clin Trials. 2000 Oct;21(5 Suppl):212S-7S
pubmed: 11018578